Concepedia

Publication | Open Access

Once-Weekly Efpeglenatide Dose-Range Effects on Glycemic Control and Body Weight in Patients With Type 2 Diabetes on Metformin or Drug Naive, Referenced to Liraglutide

DOIFull Paper Access

35

Citations

12

References

2019

Year

Julio Rosenstock, Christopher Sorli, Michael Trautmann, Cristóbal Morales, Ulrich Wendisch, George Dailey, Marcus Hompesch, In Young Choi, Jahoon Kang, John A. Stewart,
Diabetes Care

Abstract

Efpeglenatide once weekly led to significant reductions in HbA<sub>1c</sub> and weight, with a safety profile consistent with the GLP-1 RA class in patients with early T2D mostly on metformin monotherapy.

References

YearCitations

Page 1